Intestinal Ischemia after the Use of Terlipressin for Variceal Bleeding in a Patient with Primary Biliary Cirrhosis: A Case Report

Parmentier-de-Leon C; Gonzalez-Romero F, Beristain-Hernandez JL

Department of General Surgery, La Raza National Medical Center, Mexico

^*Correspondance to: José-Luis Beristain-Hernandez 

 PDF  Full Text Case Report | Open Access

Abstract:

Primary biliary cirrhosis is a chronic cholestatic liver disease characterized by destruction of small intrahepatic bile ducts, leading to fibrosis and potential cirrhosis through resulting complications. Approximately half of the patients with cirrhosis have gastroesophageal varices and one-third of all patients with varices will develop acute variceal hemorrhage. Vasopressin is a potent vasoconstrictor of both systemic and splanchnic circulation, one of the only vasoactive compounds, which have been approved by regulatory agencies for the treatment of bleeding esophageal varices. Only 3 cases of intestinal ischemia have been reported, with this paper we report a fourth.

Keywords:

Primary biliary cirrhosis; Terlipressin; Intestinal ischeamia; Variceal bleeding; Vasopressin

Cite the Article:

Parmentier-de-Leon C; Gonzalez- Romero F, Beristain-Hernandez JL. Intestinal Ischemia after the Use of Terlipressin for Variceal Bleeding in a Patient with Primary Biliary Cirrhosis: A Case Report. Ann Clin Case Rep. 2016; 1: 1020.